Recognise supply chain blood and cuts

How price cuts impact the supply chain, by Bruce Annabel and Mal Scrymgeour The 1 October price cuts were a much less bloody affair than many had imagined. The reasons we ended up experiencing relatively less pain appear to be: Crestor stayed in the Rosuvastatin WADP calculation, because it hadn’t been in the price disclosure